var data={"title":"Preventive care in adults: Recommendations","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Preventive care in adults: Recommendations</div><dl id=\"topicContributors\"><dt><span> </span>Author:</dt><dd><a href=\"https://www.uptodate.com/contents/preventive-care-in-adults-recommendations/contributors\" class=\"contributor contributor_credentials\">H Nancy Sokol, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/preventive-care-in-adults-recommendations/contributors\" class=\"contributor contributor_credentials\">Joann G Elmore, MD, MPH</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/preventive-care-in-adults-recommendations/contributors\" class=\"contributor contributor_credentials\">Judith A Melin, MA, MD, FACP</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/preventive-care-in-adults-recommendations/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Feb 16, 2018.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Quality health care for individuals includes two fundamental elements: appropriate treatment for current illness and appropriate preventive care to lessen future health decline.</p><p>This topic will summarize primary prevention and screening recommendations primarily targeting United States adults &lt;65 years old. The recommendations are a compilation of those from individual UpToDate topics, in which the rational and evidence base for the recommendations are provided.</p><p>Recommendations for older adults, an approach to prioritizing and delivering preventive services, and basic epidemiologic principles of screening are discussed elsewhere. (See <a href=\"topic.htm?path=geriatric-health-maintenance\" class=\"medical medical_review\">&quot;Geriatric health maintenance&quot;</a> and <a href=\"topic.htm?path=preventive-care-in-adults-strategies-for-prioritization-and-delivery\" class=\"medical medical_review\">&quot;Preventive care in adults: Strategies for prioritization and delivery&quot;</a> and <a href=\"topic.htm?path=evidence-based-approach-to-prevention\" class=\"medical medical_review\">&quot;Evidence-based approach to prevention&quot;</a>.)</p><p>Preventive care in special populations and disease-specific screening recommendations are discussed in more detail in specific topic reviews. As examples:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Pregnant women (see <a href=\"topic.htm?path=prenatal-care-initial-assessment\" class=\"medical medical_review\">&quot;Prenatal care: Initial assessment&quot;</a> and <a href=\"topic.htm?path=prenatal-care-second-and-third-trimesters\" class=\"medical medical_review\">&quot;Prenatal care: Second and third trimesters&quot;</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Gay men (see <a href=\"topic.htm?path=primary-care-of-gay-men-and-men-who-have-sex-with-men\" class=\"medical medical_review\">&quot;Primary care of gay men and men who have sex with men&quot;</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with HIV (see <a href=\"topic.htm?path=primary-care-of-the-hiv-infected-adult\" class=\"medical medical_review\">&quot;Primary care of the HIV-infected adult&quot;</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Cancer survivors (see <a href=\"topic.htm?path=overview-of-cancer-survivorship-care-for-primary-care-and-oncology-providers\" class=\"medical medical_review\">&quot;Overview of cancer survivorship care for primary care and oncology providers&quot;</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Patients with diabetes mellitus (see <a href=\"topic.htm?path=overview-of-medical-care-in-adults-with-diabetes-mellitus\" class=\"medical medical_review\">&quot;Overview of medical care in adults with diabetes mellitus&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">PRIORITIZING PREVENTIVE SERVICES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Preventive services should focus on priority health problems and effective interventions (<a href=\"image.htm?imageKey=PC%2F65157\" class=\"graphic graphic_table graphicRef65157 \">table 1</a>). Screening recommendations that represent discussion in UpToDate topics are summarized for adults &lt;65 years (<a href=\"image.htm?imageKey=PC%2F72728\" class=\"graphic graphic_table graphicRef72728 \">table 2</a>) and adults &ge;65 years (<a href=\"image.htm?imageKey=PC%2F75220\" class=\"graphic graphic_table graphicRef75220 \">table 3</a>). An approach to prioritizing and delivering preventive services is discussed elsewhere. (See <a href=\"topic.htm?path=preventive-care-in-adults-strategies-for-prioritization-and-delivery\" class=\"medical medical_review\">&quot;Preventive care in adults: Strategies for prioritization and delivery&quot;</a>.)</p><p><a href=\"http://www.uspreventiveservicestaskforce.org/&amp;token=UBVAQSeX8y0zcV1Zya7Dmk8miLU8OlvXKuJCF73/xXLiUt9N4xdw24A86PC13lvqaIGt+VedYp2SZlysgbeFpQ==&amp;TOPIC_ID=7574\" target=\"_blank\" class=\"external\">The US Preventive Services Task Force</a> (USPSTF) has systematically reviewed and published evidence-based recommendations for multiple clinical preventive services. (See <a href=\"topic.htm?path=preventive-care-in-adults-strategies-for-prioritization-and-delivery#H186697354\" class=\"medical medical_review\">&quot;Preventive care in adults: Strategies for prioritization and delivery&quot;, section on 'Overview of USPSTF recommendations'</a>.)</p><p class=\"headingAnchor\" id=\"H706892113\"><span class=\"h1\">OLDER ADULTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Screening, prevention, and counseling recommendations for older adults (generally targeting those &ge;65 years) is discussed in detail elsewhere. (See <a href=\"topic.htm?path=geriatric-health-maintenance\" class=\"medical medical_review\">&quot;Geriatric health maintenance&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h1\">CARDIOVASCULAR DISEASE</span></p><p class=\"headingAnchor\" id=\"H758233141\"><span class=\"h2\">Cardiovascular risk assessment</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients aged &ge;20 years should undergo cardiovascular risk assessment every three to five years. (See <a href=\"topic.htm?path=cardiovascular-disease-risk-assessment-for-primary-prevention-our-approach#H2\" class=\"medical medical_review\">&quot;Cardiovascular disease risk assessment for primary prevention: Our approach&quot;, section on 'Who should undergo estimation of CVD risk?'</a>.)</p><p>Cardiovascular disease (CVD) risk can be estimated using one of several widely available tools, each with advantages and disadvantages. A commonly used tool is the Framingham risk score (<a href=\"topic.htm?path=calculator-cardiovascular-risk-assessment-10-year-general-cardiovascular-disease-men-framingham-2008-paper\" class=\"calc calc_professional\">calculator 1</a> and <a href=\"topic.htm?path=calculator-cardiovascular-risk-assessment-10-year-general-cardiovascular-disease-women-framingham-2008-paper\" class=\"calc calc_professional\">calculator 2</a>), which provides a 10-year CVD risk. Another available calculator is the <a href=\"http://tools.acc.org/ASCVD-Risk-Estimator/&amp;token=VRaplR+cbMuyC9nZnmGwUjjI1XijifrBdozpWdA30+URGITLJqXb1ZCBV1+SPUV9sngYdIu1CIIoXhacW0fSQQ==&amp;TOPIC_ID=7574\" target=\"_blank\" class=\"external\">American College of Cardiology/American Heart Association risk calculator</a> <span class=\"nowrap\">(ACC/AHA),</span> which provides both a 10-year and lifetime CVD risk. However, there are concerns that this calculator may be inaccurate in some populations. (See <a href=\"topic.htm?path=cardiovascular-disease-risk-assessment-for-primary-prevention-risk-calculators\" class=\"medical medical_review\">&quot;Cardiovascular disease risk assessment for primary prevention: Risk calculators&quot;</a>.)</p><p>The major risk factors for CVD that are modifiable include (see <a href=\"topic.htm?path=overview-of-primary-prevention-of-coronary-heart-disease-and-stroke\" class=\"medical medical_review\">&quot;Overview of primary prevention of coronary heart disease and stroke&quot;</a>):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Diet (see <a href=\"topic.htm?path=healthy-diet-in-adults\" class=\"medical medical_review\">&quot;Healthy diet in adults&quot;</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Smoking (see <a href=\"topic.htm?path=cardiovascular-risk-of-smoking-and-benefits-of-smoking-cessation\" class=\"medical medical_review\">&quot;Cardiovascular risk of smoking and benefits of smoking cessation&quot;</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypertension (see <a href=\"topic.htm?path=cardiovascular-risks-of-hypertension\" class=\"medical medical_review\">&quot;Cardiovascular risks of hypertension&quot;</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Dyslipidemia (see <a href=\"topic.htm?path=management-of-elevated-low-density-lipoprotein-cholesterol-ldl-c-in-primary-prevention-of-cardiovascular-disease\" class=\"medical medical_review\">&quot;Management of elevated low density lipoprotein-cholesterol (LDL-C) in primary prevention of cardiovascular disease&quot;</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Obesity (see <a href=\"topic.htm?path=obesity-weight-reduction-and-cardiovascular-disease#H3\" class=\"medical medical_review\">&quot;Obesity, weight reduction, and cardiovascular disease&quot;, section on 'Obesity and cardiovascular disease'</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Physical activity (see <a href=\"topic.htm?path=the-benefits-and-risks-of-exercise#H12\" class=\"medical medical_review\">&quot;The benefits and risks of exercise&quot;, section on 'Cardiovascular disease'</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Diabetes mellitus (see <a href=\"topic.htm?path=prevalence-of-and-risk-factors-for-coronary-heart-disease-in-diabetes-mellitus#H3\" class=\"medical medical_review\">&quot;Prevalence of and risk factors for coronary heart disease in diabetes mellitus&quot;, section on 'Diabetes as a CHD equivalent'</a>)</p><p/><p>Screening for coronary heart disease in patients with risk factors is discussed in detail elsewhere. (See <a href=\"topic.htm?path=screening-for-coronary-heart-disease\" class=\"medical medical_review\">&quot;Screening for coronary heart disease&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H540017025\"><span class=\"h2\">Hypertension</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Hypertension screening is recommended for adults &ge;18 years of age [<a href=\"https://www.uptodate.com/contents/preventive-care-in-adults-recommendations/abstract/1,2\" class=\"abstract_t\">1,2</a>]. The optimal interval for screening for hypertension is not known. Most patients have their blood pressure checked at each primary care visit.</p><p>The (2015) US Preventive Services Task Force (USPSTF) guidelines recommend hypertension screening every year for adults &ge;40 years and for those who are at high risk for high blood pressure (patients with high-normal blood pressure [130 to <span class=\"nowrap\">139/85</span> to 89 mmHg] who are overweight or obese and African Americans) [<a href=\"https://www.uptodate.com/contents/preventive-care-in-adults-recommendations/abstract/1\" class=\"abstract_t\">1</a>]. Adults aged 18 to 39 years with normal blood pressure <span class=\"nowrap\">(&lt;130/85</span> mmHg) without risk factors should be rescreened every three to five years.</p><p>Recommendations for target blood pressure and treatment differ based on several factors including comorbidities, method of blood pressure measurement and age. (See <a href=\"topic.htm?path=blood-pressure-measurement-in-the-diagnosis-and-management-of-hypertension-in-adults\" class=\"medical medical_review\">&quot;Blood pressure measurement in the diagnosis and management of hypertension in adults&quot;</a> and <a href=\"topic.htm?path=overview-of-hypertension-in-adults#H2\" class=\"medical medical_review\">&quot;Overview of hypertension in adults&quot;, section on 'Definitions'</a> and <a href=\"topic.htm?path=what-is-goal-blood-pressure-in-the-treatment-of-hypertension#H126130858\" class=\"medical medical_review\">&quot;What is goal blood pressure in the treatment of hypertension?&quot;, section on 'Our approach to goal blood pressure'</a>.)</p><p class=\"headingAnchor\" id=\"H540017031\"><span class=\"h2\">Hyperlipidemia</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>We suggest that patients aged 17 to 21 years undergo one-time screening for hyperlipidemia with a non-fasting non-high-density lipoprotein (non-HDL) cholesterol; non-HDL cholesterol is the difference between total cholesterol and HDL cholesterol (<a href=\"image.htm?imageKey=PEDS%2F76041\" class=\"graphic graphic_table graphicRef76041 \">table 4</a>). (See <a href=\"topic.htm?path=dyslipidemia-in-children-definition-screening-and-diagnosis\" class=\"medical medical_review\">&quot;Dyslipidemia in children: Definition, screening, and diagnosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>For patients with a normal screen before age 21 who are also high-risk, we suggest screening for lipid abnormalities starting at age 25 for men and 35 for women. We consider patients at high risk if they have more than one risk factor (eg, diabetes, hypertension, smoking, family history) or a single risk factor that is severe (eg, several siblings with coronary heart disease in their 40s or a very heavy smoker).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>For patients with a normal screen before age 21 who are not at high risk, we suggest screening for lipid abnormalities starting at age 35 for men and 45 for women.</p><p/><p>In patients whose lipid measurements place them clearly below an appropriate threshold for treatment, we suggest repeating measurements every five years. In patients who have had more than one lipid screen, we suggest stopping screening at age 65. Ongoing assessment of cardiovascular risk can be based on risk factors and earlier lipid levels. (See <a href=\"topic.htm?path=screening-for-lipid-disorders-in-adults\" class=\"medical medical_review\">&quot;Screening for lipid disorders in adults&quot;</a>.)</p><p>When a decision is made to screen lipids to assess cardiovascular risk, we suggest measuring the total cholesterol and HDL cholesterol rather than a complete lipid profile or other lipid marker or fractions. Testing for total cholesterol and HDL cholesterol does not require that the patient be fasting. (See <a href=\"topic.htm?path=screening-for-lipid-disorders-in-adults#H7832879\" class=\"medical medical_review\">&quot;Screening for lipid disorders in adults&quot;, section on 'Choice of tests'</a>.)</p><p class=\"headingAnchor\" id=\"H443482109\"><span class=\"h2\">Obesity</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We suggest screening all patients for obesity with body mass index (BMI) (<a href=\"topic.htm?path=calculator-body-mass-index-bmi-quetelets-index-in-adults\" class=\"calc calc_professional\">calculator 3</a>). Selection of patients for treatment should be based on risk factor assessment. (See <a href=\"topic.htm?path=obesity-in-adults-prevalence-screening-and-evaluation\" class=\"medical medical_review\">&quot;Obesity in adults: Prevalence, screening, and evaluation&quot;</a> and <a href=\"topic.htm?path=obesity-in-adults-overview-of-management\" class=\"medical medical_review\">&quot;Obesity in adults: Overview of management&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H18816530\"><span class=\"h2\">Physical activity</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We suggest counseling patients about exercise to promote maintenance of healthy weight and physical activity for all patients. (See <a href=\"topic.htm?path=the-benefits-and-risks-of-exercise\" class=\"medical medical_review\">&quot;The benefits and risks of exercise&quot;</a> and <a href=\"topic.htm?path=exercise-and-fitness-in-the-prevention-of-cardiovascular-disease\" class=\"medical medical_review\">&quot;Exercise and fitness in the prevention of cardiovascular disease&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H706893344\"><span class=\"h2\">Diabetes mellitus</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>For adults with hypertension or hyperlipidemia, as well as for those aged 40 to 70 years with a BMI &ge;25 <span class=\"nowrap\">kg/m<sup>2</sup>,</span> we suggest screening for type 2 diabetes as part of cardiovascular risk assessment. (See <a href=\"topic.htm?path=screening-for-type-2-diabetes-mellitus#H13\" class=\"medical medical_review\">&quot;Screening for type 2 diabetes mellitus&quot;, section on 'A suggested approach'</a>.)</p><p>When convenient, we recommend screening using fasting plasma glucose (measured in a laboratory rather than using a fingerstick sample with a meter). Simultaneously ordering an A1C is a reasonable option, especially in patients with the highest risk of diabetes (eg, those with multiple risk factors or abnormal glucose metabolism). When obtaining a fasting specimen is inconvenient, we recommend screening using an A1C.</p><p class=\"headingAnchor\" id=\"H706894080\"><span class=\"h2\">Aspirin for primary prevention</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Decisions regarding <a href=\"topic.htm?path=aspirin-drug-information\" class=\"drug drug_general\">aspirin</a> for primary prevention of CVD should be made on an individual basis. Factors to be considered are discussed in detail elsewhere. (See <a href=\"topic.htm?path=aspirin-in-the-primary-prevention-of-cardiovascular-disease-and-cancer\" class=\"medical medical_review\">&quot;Aspirin in the primary prevention of cardiovascular disease and cancer&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H443482115\"><span class=\"h2\">Routine electrocardiogram</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A routine electrocardiogram (ECG), even for a &quot;baseline,&quot; is not indicated in asymptomatic adults at low risk for CVD. (See <a href=\"topic.htm?path=screening-for-coronary-heart-disease#H349915881\" class=\"medical medical_review\">&quot;Screening for coronary heart disease&quot;, section on 'Resting ECG and ambulatory ECG monitoring'</a>.)</p><p class=\"headingAnchor\" id=\"H200699475\"><span class=\"h2\">Nontraditional measures</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We do not recommend screening low-risk patients with nontraditional measures (eg, C-reactive protein, carotid artery intima-media thickness, coronary artery calcification, homocysteine, or lipoprotein[a]).</p><p>However, as discussed separately, these measures may be warranted for patients without known CVD who are at intermediate risk for CVD and for whom a more definite estimate of CVD risk would change management:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>C-reactive protein (see <a href=\"topic.htm?path=c-reactive-protein-in-cardiovascular-disease\" class=\"medical medical_review\">&quot;C-reactive protein in cardiovascular disease&quot;</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Carotid artery intima-media thickness (see <a href=\"topic.htm?path=carotid-intima-media-thickness\" class=\"medical medical_review\">&quot;Carotid intima-media thickness&quot;</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Coronary artery calcification by computed tomography (CT) (see <a href=\"topic.htm?path=diagnostic-and-prognostic-implications-of-coronary-artery-calcification\" class=\"medical medical_review\">&quot;Diagnostic and prognostic implications of coronary artery calcification&quot;</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Homocysteine (see <a href=\"topic.htm?path=overview-of-homocysteine\" class=\"medical medical_review\">&quot;Overview of homocysteine&quot;</a>)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lipoprotein(a) (see <a href=\"topic.htm?path=lipoprotein-a-and-cardiovascular-disease\" class=\"medical medical_review\">&quot;Lipoprotein(a) and cardiovascular disease&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H9\"><span class=\"h1\">CANCER</span></p><p class=\"headingAnchor\" id=\"H540019999\"><span class=\"h2\">Prevention</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A number of measures can be taken to prevent cancer, including (see <a href=\"topic.htm?path=cancer-prevention\" class=\"medical medical_review\">&quot;Cancer prevention&quot;</a>):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Avoidance of tobacco</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Being physically active</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Maintaining a healthy weight</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Eating a diet rich in fruits, vegetables, and whole grains, and low in <span class=\"nowrap\">saturated/trans</span> fat</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Limiting alcohol consumption</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Protecting against sexually transmitted infections</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Avoiding excess sun</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Getting regular screening for breast, cervical, and colorectal cancer</p><p/><p>Prevention is most effective for cancers that are strongly and causally associated with tobacco use: cancers of the oropharynx, bladder, esophagus, and lung. (See <a href=\"topic.htm?path=cancer-prevention#H2\" class=\"medical medical_review\">&quot;Cancer prevention&quot;, section on 'Tobacco use'</a>.)</p><p>Decision regarding <a href=\"topic.htm?path=aspirin-drug-information\" class=\"drug drug_general\">aspirin</a> for primary prevention of cancer should be made on an individual basis. Factors to be considered are discussed in detail elsewhere. (See <a href=\"topic.htm?path=aspirin-in-the-primary-prevention-of-cardiovascular-disease-and-cancer#H1761545\" class=\"medical medical_review\">&quot;Aspirin in the primary prevention of cardiovascular disease and cancer&quot;, section on 'Prevention of cancer'</a> and <a href=\"topic.htm?path=nsaids-including-aspirin-role-in-prevention-of-colorectal-cancer\" class=\"medical medical_review\">&quot;NSAIDs (including aspirin): Role in prevention of colorectal cancer&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Breast cancer</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Major risk factors for breast cancer in women are age, genetic predisposition, and estrogen exposure (<a href=\"image.htm?imageKey=PC%2F64508\" class=\"graphic graphic_table graphicRef64508 \">table 5</a>). Evaluation for hereditary breast and ovarian cancer syndromes should be considered in men and women with a personal or family history that is concerning. (See <a href=\"topic.htm?path=factors-that-modify-breast-cancer-risk-in-women\" class=\"medical medical_review\">&quot;Factors that modify breast cancer risk in women&quot;</a> and <a href=\"topic.htm?path=screening-for-breast-cancer-strategies-and-recommendations#H1353925605\" class=\"medical medical_review\">&quot;Screening for breast cancer: Strategies and recommendations&quot;, section on 'Clinical use of risk prediction models'</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Family history &ndash; Men and women at risk for hereditary breast and ovarian cancer syndromes should be identified by taking a thorough personal and family history, with a focus on both the maternal and paternal sides of the family (<a href=\"image.htm?imageKey=ONC%2F65717\" class=\"graphic graphic_table graphicRef65717 \">table 6</a>). Patients with concerning family history should be referred to a genetic counselor for a formal genetic assessment. Recommendations for screening in patients with a hereditary breast and ovarian cancer syndrome are discussed in detail elsewhere. (See <a href=\"topic.htm?path=overview-of-hereditary-breast-and-ovarian-cancer-syndromes\" class=\"medical medical_review\">&quot;Overview of hereditary breast and ovarian cancer syndromes&quot;</a> and <a href=\"topic.htm?path=management-of-patients-at-high-risk-for-breast-and-ovarian-cancer\" class=\"medical medical_review\">&quot;Management of patients at high risk for breast and ovarian cancer&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Screening for average-risk women &ndash; Clinicians should discuss breast cancer screening with all women starting at age 40. The decision to perform mammography should be determined by individual patient risk and values through shared decision-making (<a href=\"image.htm?imageKey=PC%2F94497\" class=\"graphic graphic_table graphicRef94497 \">table 7</a>). It should be emphasized that the relative benefits and harms of screening change as a woman gets older. The absolute benefits, in terms of numbers of lives saved, are lower for younger women than for older women because of both decreased incidence of breast cancer and sensitivity of mammography in younger women.</p><p/><p class=\"bulletIndent1\">All women should receive counseling about the benefits and harms of screening and understand that mammography is associated with a substantial risk for false-positive findings. Given declining mortality rates from breast cancer after advances in treatment protocols, some women may choose to forego screening.</p><p/><p class=\"bulletIndent1\">For women who choose to undergo screening, the ideal interval for screening mammography is not known. We suggest screening every two years.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Age to stop screening &ndash; We suggest that breast cancer screening with mammography be continued as long as a woman has a life expectancy of at least 10 years.</p><p/><p>We suggest that women being screened for breast cancer not undergo clinical breast examination.</p><p>We suggest that breast self-examination (BSE) not be performed except by women who express a desire to do so and who have received careful instruction to differentiate normal tissue from suspicious lumps. BSE should only be performed as an adjunct to mammography and clinical breast examination, not as a substitute for these screening methods. (See <a href=\"topic.htm?path=screening-for-breast-cancer-evidence-for-effectiveness-and-harms#H3757879\" class=\"medical medical_review\">&quot;Screening for breast cancer: Evidence for effectiveness and harms&quot;, section on 'Breast self-examination'</a>.)</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h2\">Cervical cancer</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We recommend cervical cancer screening for immunocompetent women ages 21 to 65 years who have an intact cervix. (See <a href=\"topic.htm?path=screening-for-cervical-cancer\" class=\"medical medical_review\">&quot;Screening for cervical cancer&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>For average-risk women (without human immunodeficiency virus [HIV] or immunocompromise) aged 21 to 29, we suggest Pap smear screening every three years. (See <a href=\"topic.htm?path=screening-for-cervical-cancer#H3213478\" class=\"medical medical_review\">&quot;Screening for cervical cancer&quot;, section on 'Women &lt;30 years'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>For average-risk women (without HIV or immunocompromise) aged 30 to 64, we suggest either Pap smear screening every three years or co-testing (Pap smear and human papillomavirus [HPV] testing) every five years if both initial tests are negative. (See <a href=\"topic.htm?path=screening-for-cervical-cancer#H3570212629\" class=\"medical medical_review\">&quot;Screening for cervical cancer&quot;, section on 'Women &ge;30 years'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Women &ge;65 years who have had adequate negative prior screening and are not at increased risk do not need to be screened. (See <a href=\"topic.htm?path=screening-for-cervical-cancer#H3219162\" class=\"medical medical_review\">&quot;Screening for cervical cancer&quot;, section on 'Adequate prior screening'</a>.)</p><p/><p class=\"bulletIndent1\">However, even in older women who have been adequately screened, it may be reasonable to continue to screen those with good life expectancy who have risk factors for cervical cancer. Risk factors include a history of an abnormal Pap test, current smoker or history of smoking, previous HPV-related disease, or new partners. We continue to offer screening to women with good life expectancy who have risk factors for cervical cancer until about age 80, but the upper age limit may vary with the risk factor (eg, women with good life expectancy and a history of CIN 2 or greater should be screened for at least 20 years following diagnosis).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Older women who have not been adequately screened should be screened until age 70 to 75 years. (See <a href=\"topic.htm?path=screening-for-cervical-cancer#H3214712\" class=\"medical medical_review\">&quot;Screening for cervical cancer&quot;, section on 'Inadequate prior screening'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Women who have had a total hysterectomy for reasons other than cervical cancer or high-grade cervical cancer precursors need not be screened. (See <a href=\"topic.htm?path=screening-for-cervical-cancer#H3215104\" class=\"medical medical_review\">&quot;Screening for cervical cancer&quot;, section on 'Prior hysterectomy'</a>.)</p><p/><p>Recommendations for screening for cervical cancer in women with HIV, women immunocompromised for other reasons, and other special populations are discussed in detail elsewhere. (See <a href=\"topic.htm?path=screening-for-cervical-cancer-in-hiv-infected-women-and-adolescents\" class=\"medical medical_review\">&quot;Screening for cervical cancer in HIV-infected women and adolescents&quot;</a> and <a href=\"topic.htm?path=screening-for-cervical-cancer#H546745154\" class=\"medical medical_review\">&quot;Screening for cervical cancer&quot;, section on 'Factors that affect risk'</a>.)</p><p class=\"headingAnchor\" id=\"H179776045\"><span class=\"h2\">Ovarian cancer</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Screening for ovarian cancer is not recommended for average-risk women. (See <a href=\"topic.htm?path=screening-for-ovarian-cancer#H20\" class=\"medical medical_review\">&quot;Screening for ovarian cancer&quot;, section on 'Women at average risk'</a>.)</p><p>Screening for ovarian cancer in women at higher risk is discussed in detail separately. (See <a href=\"topic.htm?path=screening-for-ovarian-cancer#H21\" class=\"medical medical_review\">&quot;Screening for ovarian cancer&quot;, section on 'Women at increased risk'</a>.)</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h2\">Colorectal cancer</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The age of initiation and frequency of colorectal cancer screening varies with the risk:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>No risk factors &ndash; We recommend that average-risk patients aged 50 and older be screened for colorectal cancer. We suggest that screening be continued until the life expectancy for an individual patient is estimated as less than 10 years. For most patients, it is reasonable to stop screening at age 75 years or 85 years at the latest. One-time screening with colonoscopy (to age 83) or sigmoidoscopy (to age 84) is advised for adults who have never been screened for colorectal cancer. (See <a href=\"topic.htm?path=screening-for-colorectal-cancer-strategies-in-patients-at-average-risk#H12\" class=\"medical medical_review\">&quot;Screening for colorectal cancer: Strategies in patients at average risk&quot;, section on 'Guidelines for average-risk screening'</a> and <a href=\"topic.htm?path=screening-for-colorectal-cancer-strategies-in-patients-at-average-risk#H21\" class=\"medical medical_review\">&quot;Screening for colorectal cancer: Strategies in patients at average risk&quot;, section on 'Screening in older adults'</a>.)</p><p/><p class=\"bulletIndent1\">The recommended interval varies depending upon the screening strategy (<a href=\"image.htm?imageKey=PC%2F108744\" class=\"graphic graphic_table graphicRef108744 \">table 8</a>). Patients should be advised of the risks and benefits of different screening options. The decision about which option to select should be made between the patient and clinician, weighing factors of effectiveness, safety, cost, and availability of the screening tests. (See <a href=\"topic.htm?path=screening-for-colorectal-cancer-strategies-in-patients-at-average-risk#H10\" class=\"medical medical_review\">&quot;Screening for colorectal cancer: Strategies in patients at average risk&quot;, section on 'Comparison of tests'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Family history of colorectal cancer. (See <a href=\"topic.htm?path=screening-for-colorectal-cancer-in-patients-with-a-family-history-of-colorectal-cancer\" class=\"medical medical_review\">&quot;Screening for colorectal cancer in patients with a family history of colorectal cancer&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Familial adenomatous polyposis. (See <a href=\"topic.htm?path=familial-adenomatous-polyposis-screening-and-management-of-patients-and-families\" class=\"medical medical_review\">&quot;Familial adenomatous polyposis: Screening and management of patients and families&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lynch syndrome. (See <a href=\"topic.htm?path=lynch-syndrome-hereditary-nonpolyposis-colorectal-cancer-screening-and-management\" class=\"medical medical_review\">&quot;Lynch syndrome (hereditary nonpolyposis colorectal cancer): Screening and management&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Peutz-Jeghers syndrome. (See <a href=\"topic.htm?path=juvenile-polyposis-syndrome\" class=\"medical medical_review\">&quot;Juvenile polyposis syndrome&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Inflammatory bowel disease. (See <a href=\"topic.htm?path=surveillance-and-management-of-dysplasia-in-patients-with-inflammatory-bowel-disease\" class=\"medical medical_review\">&quot;Surveillance and management of dysplasia in patients with inflammatory bowel disease&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H13\"><span class=\"h2\">Lung cancer</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Smoking tobacco products (primarily cigarettes) is the most important risk factor for the development of lung cancer. All patients who smoke should be counselled to quit smoking as the most effective intervention to reduce the risk of lung cancer. (See <a href=\"topic.htm?path=cigarette-smoking-and-other-possible-risk-factors-for-lung-cancer\" class=\"medical medical_review\">&quot;Cigarette smoking and other possible risk factors for lung cancer&quot;</a> and <a href=\"topic.htm?path=overview-of-smoking-cessation-management-in-adults\" class=\"medical medical_review\">&quot;Overview of smoking cessation management in adults&quot;</a>.)</p><p>We suggest annual screening with low-dose helical computed tomography (CT) for patients in whom the cost of screening is not an issue if they are in good health, at risk for lung cancer (age 55 to 74 years; history of smoking at least 30 pack-years and, if a former smoker, had quit within the previous 15 years), and have access to centers with similar capabilities as the National Lung Screening Trial (NLST). (See <a href=\"topic.htm?path=screening-for-lung-cancer#H23\" class=\"medical medical_review\">&quot;Screening for lung cancer&quot;, section on 'Synthesizing the available evidence'</a> and <a href=\"topic.htm?path=screening-for-lung-cancer#H25\" class=\"medical medical_review\">&quot;Screening for lung cancer&quot;, section on 'Counseling for screening'</a>.)</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h2\">Prostate cancer</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Individual patient preferences for specific health outcomes are a deciding factor in determining whether to screen for prostate cancer. Men who are potential candidates for screening should be engaged in discussions or decision-making processes that inform them and evoke these preferences. (See <a href=\"topic.htm?path=screening-for-prostate-cancer#H33\" class=\"medical medical_review\">&quot;Screening for prostate cancer&quot;, section on 'Approach to screening'</a>.)</p><p>Health care providers should periodically discuss prostate cancer screening with men who are expected to live at least 10 years and are old enough to be at significant risk for prostate cancer. We suggest that discussions begin at age 50 in average-risk men. We suggest discussions begin at age 40 to 45 in men at high risk for prostate cancer (including black men, men with a family history of prostate cancer, particularly in relatives younger than age 65, and men who are known or likely to have the <em>BRCA1</em> or <em>BRCA2</em> mutations).</p><p>When a decision is made to screen, we suggest that screening be performed with prostate-specific antigen (PSA) tests at intervals ranging from every two to four years. We suggest not performing digital rectal examination as part of screening. (See <a href=\"topic.htm?path=screening-for-prostate-cancer#H36\" class=\"medical medical_review\">&quot;Screening for prostate cancer&quot;, section on 'Frequency and method of screening'</a>.)</p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h2\">Melanoma</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>We recommend that individuals at highest risk (history suggesting a familial melanoma syndrome or with multiple atypical nevi) have a regular full-body skin examination by a clinician with skin expertise. The optimal frequency for such examination is unknown. (See <a href=\"topic.htm?path=screening-and-early-detection-of-melanoma-in-adults-and-adolescents\" class=\"medical medical_review\">&quot;Screening and early detection of melanoma in adults and adolescents&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>We suggest that persons at higher risk for melanoma (white men over 50 years, individuals with a history of significant sunburn, or multiple moles) have a periodic full body skin examination performed by a clinician who has had appropriate training in the identification of melanoma.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>We also suggest that individuals at high risk for skin cancer be counseled about self-skin examination and advised to examine their skin regularly and notify their clinicians if moles change.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>For patients without identified increased risk, we agree with the US Preventive Services Task Force (USPSTF) that clinicians remain vigilant for any suspicious lesions identified in the course of a routine or sick visit (opportunistic case finding) and make appropriate referrals for further evaluation of all such lesions.</p><p/><p class=\"headingAnchor\" id=\"H18\"><span class=\"h1\">IMMUNIZATION</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The Centers for Disease Control and Prevention (CDC) makes annual recommendations for immunizations in adults (<a href=\"image.htm?imageKey=ID%2F82634\" class=\"graphic graphic_figure graphicRef82634 \">figure 1</a> and <a href=\"image.htm?imageKey=ID%2F62130\" class=\"graphic graphic_figure graphicRef62130 \">figure 2</a>). (See <a href=\"topic.htm?path=standard-immunizations-for-nonpregnant-adults\" class=\"medical medical_review\">&quot;Standard immunizations for nonpregnant adults&quot;</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Influenza vaccine</strong> &ndash; We recommend annual influenza vaccination for all adults. (See <a href=\"topic.htm?path=seasonal-influenza-vaccination-in-adults\" class=\"medical medical_review\">&quot;Seasonal influenza vaccination in adults&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Tetanus, diphtheria, and acellular pertussis vaccination <span class=\"nowrap\">(Td/Tdap)</strong></span> &ndash; The CDC recommends a single dose of Tdap in place of Td for all adults aged 19 years and older who have not received Tdap previously [<a href=\"https://www.uptodate.com/contents/preventive-care-in-adults-recommendations/abstract/3\" class=\"abstract_t\">3</a>]. Adults should receive a Td booster every 10 years. (See <a href=\"topic.htm?path=tetanus-diphtheria-toxoid-vaccination-in-adults\" class=\"medical medical_review\">&quot;Tetanus-diphtheria toxoid vaccination in adults&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><a href=\"topic.htm?path=varicella-virus-vaccine-drug-information\" class=\"drug drug_general\">Varicella vaccine</a> &ndash; We recommend routine varicella vaccination for healthy persons &gt;13 years of age without evidence of immunity. (See <a href=\"topic.htm?path=vaccination-for-the-prevention-of-chickenpox-primary-varicella-infection#H21209874\" class=\"medical medical_review\">&quot;Vaccination for the prevention of chickenpox (primary varicella infection)&quot;, section on 'Adolescents and adults'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Human papillomavirus vaccines</strong> &ndash; We recommend human papillomavirus vaccine (HPV) for females up to age 26 years who have not been previously vaccinated, for males up to age 21 who have not been previously vaccinated, and for men who have sex with men up to age 26. (See <a href=\"topic.htm?path=human-papillomavirus-vaccination\" class=\"medical medical_review\">&quot;Human papillomavirus vaccination&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Zoster vaccine</strong> &ndash; We suggest zoster vaccination in most individuals who are 50 years of age or older.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Pneumococcal vaccines</strong> &ndash; We recommend pneumococcal vaccination for all adults 19 to 64 years who have a condition that increases the risk of pneumococcal disease (<a href=\"image.htm?imageKey=ID%2F86782\" class=\"graphic graphic_table graphicRef86782 \">table 9</a>). It is also recommended for all adults &ge;65 years. (See <a href=\"topic.htm?path=pneumococcal-vaccination-in-adults\" class=\"medical medical_review\">&quot;Pneumococcal vaccination in adults&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Meningococcal vaccines</strong> &ndash; Meningococcal vaccination is recommended in the United States based on age <span class=\"nowrap\">and/or</span> risk factor (<a href=\"image.htm?imageKey=ID%2F71265\" class=\"graphic graphic_table graphicRef71265 \">table 10</a>). (See <a href=\"topic.htm?path=meningococcal-vaccines\" class=\"medical medical_review\">&quot;Meningococcal vaccines&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Hepatitis B vaccination</strong> &ndash; Patients at high risk for hepatitis B virus (HBV) (<a href=\"image.htm?imageKey=PEDS%2F116656\" class=\"graphic graphic_table graphicRef116656 \">table 11</a>) should be vaccinated, including diabetic adults &lt;60 years. For diabetic patients &ge;60 years, vaccination may be warranted based on likelihood of acquiring hepatitis B and immune response. (See <a href=\"topic.htm?path=hepatitis-b-virus-vaccination#H8\" class=\"medical medical_review\">&quot;Hepatitis B virus vaccination&quot;, section on 'Other high-risk groups'</a>.)</p><p/><p>Additional immunizations may be necessary for patients in particular risk groups (eg, health care workers, asplenia, adults with cancer). Please see appropriate topics for details. (See <a href=\"topic.htm?path=immunizations-for-health-care-providers\" class=\"medical medical_review\">&quot;Immunizations for health care providers&quot;</a> and <a href=\"topic.htm?path=prevention-of-sepsis-in-the-asplenic-patient#H4\" class=\"medical medical_review\">&quot;Prevention of sepsis in the asplenic patient&quot;, section on 'Immunizations'</a> and <a href=\"topic.htm?path=immunizations-in-adults-with-cancer\" class=\"medical medical_review\">&quot;Immunizations in adults with cancer&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H28\"><span class=\"h1\">SEXUALLY TRANSMITTED AND BLOODBORNE INFECTIONS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Prevention and screening for sexually transmitted infections in asymptomatic patients and pregnant women are discussed in detail elsewhere. (See <a href=\"topic.htm?path=prevention-of-sexually-transmitted-infections\" class=\"medical medical_review\">&quot;Prevention of sexually transmitted infections&quot;</a> and <a href=\"topic.htm?path=screening-for-sexually-transmitted-infections\" class=\"medical medical_review\">&quot;Screening for sexually transmitted infections&quot;</a> and <a href=\"topic.htm?path=prenatal-care-initial-assessment#H13\" class=\"medical medical_review\">&quot;Prenatal care: Initial assessment&quot;, section on 'Infection'</a>.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Chlamydia</strong> &ndash; We suggest chlamydia screening for all sexually active women &lt;25 years and sexually active women &ge;25 years with risk factors (eg, a history of prior chlamydial or other sexually transmitted infection, new or multiple sex partners, sex partner with concurrent partners, sex partner with a sexually transmitted infection, or exchanging sex for drugs or money). (See <a href=\"topic.htm?path=screening-for-sexually-transmitted-infections#H88324495\" class=\"medical medical_review\">&quot;Screening for sexually transmitted infections&quot;, section on 'Females'</a>.)</p><p/><p class=\"bulletIndent1\">We also suggest screening men in high-risk populations (men attending clinics for sexually transmitted infections, men who have sex with men or men in correctional facilities). (See <a href=\"topic.htm?path=screening-for-sexually-transmitted-infections#H88324501\" class=\"medical medical_review\">&quot;Screening for sexually transmitted infections&quot;, section on 'Males'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Gonorrhea</strong> &ndash; Routine screening should be offered to sexually active patients at high risk of infection including (see <a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-neisseria-gonorrhoeae-infection-in-adults-and-adolescents#H167171555\" class=\"medical medical_review\">&quot;Clinical manifestations and diagnosis of Neisseria gonorrhoeae infection in adults and adolescents&quot;, section on 'Asymptomatic patients'</a>):</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Human immunodeficiency virus (HIV)-infected men and women</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Sexually active women &lt;25 years old</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Individuals with new or many sexual partners</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Men who have sex with men</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Sexually active individuals living in areas of high <em>Neisseria gonorrhoeae </em>prevalence</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Individuals with a history of other sexually transmitted infection(s)</p><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>Women &le;35 years old and men &le;30 years old entering correctional facilities, at intake</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Hepatitis B</strong> &ndash; We recommend screening high-risk persons for hepatitis B virus (<a href=\"image.htm?imageKey=GAST%2F55052\" class=\"graphic graphic_table graphicRef55052 \">table 12</a>). (See <a href=\"topic.htm?path=hepatitis-b-virus-screening-and-diagnosis#H1136182310\" class=\"medical medical_review\">&quot;Hepatitis B virus: Screening and diagnosis&quot;, section on 'Who should be tested'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Hepatitis C</strong> &ndash; We recommend one-time screening for all persons in the United States born between 1945 and 1965 and other patients with risk factors for chronic hepatitis C infection (<a href=\"image.htm?imageKey=ID%2F98092\" class=\"graphic graphic_table graphicRef98092 \">table 13</a>). (See <a href=\"topic.htm?path=screening-for-chronic-hepatitis-c-virus-infection#H10470397\" class=\"medical medical_review\">&quot;Screening for chronic hepatitis C virus infection&quot;, section on 'Our approach'</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>HIV infection</strong> &ndash; We recommend screening adults for HIV infection until age 75. (See <a href=\"topic.htm?path=screening-and-diagnostic-testing-for-hiv-infection\" class=\"medical medical_review\">&quot;Screening and diagnostic testing for HIV infection&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Syphilis</strong> &ndash; We recommend screening for syphilis in patients considered high risk. These include men who have sex with men, inmates, persons with multiple sexual partners, patients with another sexually transmitted disease, and sexually active HIV-infected patients. (See <a href=\"topic.htm?path=syphilis-screening-and-diagnostic-testing#H2\" class=\"medical medical_review\">&quot;Syphilis: Screening and diagnostic testing&quot;, section on 'Whom to test'</a>.)</p><p/><p>Additional screening may be necessary for patients in particular risk groups (eg, commercial sex workers, persons in correctional facilities, persons diagnosed with another sexually transmitted infection). (See <a href=\"topic.htm?path=screening-for-sexually-transmitted-infections\" class=\"medical medical_review\">&quot;Screening for sexually transmitted infections&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H18815683\"><span class=\"h1\">PSYCHOSOCIAL HEALTH CONCERNS</span></p><p class=\"headingAnchor\" id=\"H706893450\"><span class=\"h2\">Depression</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We suggest screening adults for depression when personnel or systems are in place to ensure appropriate follow-up and management of patients who screen positive. There is limited evidence to guide the optimal frequency of screening for depression. To facilitate ease of implementation, we support screening at the time of a routine health visit. (See <a href=\"topic.htm?path=screening-for-depression-in-adults#H22016492\" class=\"medical medical_review\">&quot;Screening for depression in adults&quot;, section on 'Screening implementation'</a>.)</p><p>For practices choosing to screen, the two-item Patient Health Questionnaire (PHQ), either as a verbal or written screen, is easily administered with reasonable performance characteristics (<a href=\"image.htm?imageKey=PC%2F89663\" class=\"graphic graphic_table graphicRef89663 \">table 14</a>). A positive screen should be followed by a clinical interview, facilitated with the PHQ-9 (<a href=\"image.htm?imageKey=PC%2F59307\" class=\"graphic graphic_table graphicRef59307 \">table 15</a>) or a similar instrument, to diagnose depression. (See <a href=\"topic.htm?path=screening-for-depression-in-adults#H22016485\" class=\"medical medical_review\">&quot;Screening for depression in adults&quot;, section on 'Screening instruments'</a>.)</p><p class=\"headingAnchor\" id=\"H32\"><span class=\"h2\">Substance related problems</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Alcohol</strong> &ndash; We recommend that all adult primary care patients be screened for unhealthy alcohol use. In general, annual screening is suggested. We suggest the single-item alcohol screening question for most primary care practices. Single-item screen starts with the question, &quot;Do you sometimes drink beer, wine, or other alcoholic beverages?&quot; If yes, then the clinician can follow up with, &quot;How many times in the past year have you had five (four for women) or more drinks in a day?&quot;</p><p/><p class=\"bulletIndent1\">The AUDIT-C (<a href=\"image.htm?imageKey=PC%2F53246\" class=\"graphic graphic_table graphicRef53246 \">table 16</a>) is an alternative for offices with more resources (eg, staff, time, and ability to automate administration and scoring). (See <a href=\"topic.htm?path=screening-for-unhealthy-use-of-alcohol-and-other-drugs-in-primary-care\" class=\"medical medical_review\">&quot;Screening for unhealthy use of alcohol and other drugs in primary care&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Tobacco</strong> &ndash; Clinicians should ask all patients whether they use tobacco, and in what form. Smokers should be advised to quit. (See <a href=\"topic.htm?path=overview-of-smoking-cessation-management-in-adults\" class=\"medical medical_review\">&quot;Overview of smoking cessation management in adults&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Other drug use</strong> &ndash; Patients should also be assessed for unhealthy use of drugs. (See <a href=\"topic.htm?path=clinical-assessment-of-substance-use-disorders\" class=\"medical medical_review\">&quot;Clinical assessment of substance use disorders&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"H706893543\"><span class=\"h2\">Intimate partner violence</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>All patients with specific findings in the history <span class=\"nowrap\">and/or</span> physical examination should be asked about intimate partner violence (<a href=\"image.htm?imageKey=PC%2F53373\" class=\"graphic graphic_table graphicRef53373 \">table 17</a>). Given the high prevalence of intimate partner violence, and the lack of harm and potential benefits of screening, we suggest routine screening for all patients on initial visits to primary care clinicians, to obstetrician-gynecologists, to the emergency department, and on hospital admission. (See <a href=\"topic.htm?path=intimate-partner-violence-diagnosis-and-screening\" class=\"medical medical_review\">&quot;Intimate partner violence: Diagnosis and screening&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H18815956\"><span class=\"h1\">OSTEOPOROSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>We suggest osteoporosis screening in the following groups (see <a href=\"topic.htm?path=screening-for-osteoporosis\" class=\"medical medical_review\">&quot;Screening for osteoporosis&quot;</a> and <a href=\"topic.htm?path=osteoporotic-fracture-risk-assessment\" class=\"medical medical_review\">&quot;Osteoporotic fracture risk assessment&quot;</a>):</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Postmenopausal women &lt;65 years with risk factors for osteoporosis (<a href=\"image.htm?imageKey=ENDO%2F76445\" class=\"graphic graphic_table graphicRef76445 \">table 18</a>).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Men with clinical manifestation of low bone mass, history of low trauma fracture, risk factors for fracture (such as androgen deprivation therapy for prostate cancer, hypogonadism, primary hyperparathyroidism, or intestinal disorders).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>All women &ge;65 years. (See <a href=\"topic.htm?path=geriatric-health-maintenance#H19\" class=\"medical medical_review\">&quot;Geriatric health maintenance&quot;, section on 'Osteoporosis'</a>.)</p><p/><p>There are several modalities to evaluate bone density. Dual-energy x-ray absorptiometry (DXA) is most commonly used. (See <a href=\"topic.htm?path=overview-of-dual-energy-x-ray-absorptiometry\" class=\"medical medical_review\">&quot;Overview of dual-energy x-ray absorptiometry&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H18816040\"><span class=\"h1\">VASCULAR DISEASE</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Abdominal aortic aneurysm</strong> &ndash; Screening for abdominal aortic aneurysm (AAA) is not recommended for adults &lt;65 years. (See <a href=\"topic.htm?path=screening-for-abdominal-aortic-aneurysm\" class=\"medical medical_review\">&quot;Screening for abdominal aortic aneurysm&quot;</a>.)</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>We recommend one-time ultrasound screening for AAA in men ages 65 to 75 years who are current or former smokers.</p><p/><p class=\"bulletIndent2\"><span class=\"glyph\">&#8226;</span>We also suggest one-time screening for AAA in men ages 65 to 75 who have never smoked but who have a first-degree relative who required repair of an AAA or died from a ruptured AAA.</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Carotid artery stenosis</strong> &ndash; We do not recommend screening (either by auscultation for carotid bruit or by carotid ultrasound) asymptomatic patients for carotic artery stenosis. (See <a href=\"topic.htm?path=screening-for-asymptomatic-carotid-artery-stenosis\" class=\"medical medical_review\">&quot;Screening for asymptomatic carotid artery stenosis&quot;</a>.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span><strong>Peripheral artery disease</strong> &ndash; We do not suggest screening for peripheral artery disease. (See <a href=\"topic.htm?path=screening-for-lower-extremity-peripheral-artery-disease\" class=\"medical medical_review\">&quot;Screening for lower extremity peripheral artery disease&quot;</a>.)</p><p/><p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\"><span class=\"h1\">INFORMATION FOR PATIENTS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>UpToDate offers two types of patient education materials, &quot;The Basics&quot; and &quot;Beyond the Basics.&quot; The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &quot;patient info&quot; and the keyword(s) of interest.)</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Basics topics (see <a href=\"topic.htm?path=breast-cancer-screening-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Breast cancer screening (The Basics)&quot;</a> and <a href=\"topic.htm?path=lung-cancer-screening-the-basics\" class=\"medical medical_basics\">&quot;Patient education: Lung cancer screening (The Basics)&quot;</a>)</p><p/><p class=\"headingAnchor\" id=\"H39\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Recommendations for preventive services are summarized for adults &lt;65 years (<a href=\"image.htm?imageKey=PC%2F72728\" class=\"graphic graphic_table graphicRef72728 \">table 2</a>) and adults &ge;65 years (<a href=\"image.htm?imageKey=PC%2F75220\" class=\"graphic graphic_table graphicRef75220 \">table 3</a>). (See <a href=\"#H2\" class=\"local\">'Prioritizing preventive services'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Preventive services for a given patient should be prioritized according to his or her age, risk factors and preferences. This is discussed separately. (See <a href=\"topic.htm?path=preventive-care-in-adults-strategies-for-prioritization-and-delivery\" class=\"medical medical_review\">&quot;Preventive care in adults: Strategies for prioritization and delivery&quot;</a>.)</p></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/preventive-care-in-adults-recommendations/abstract/1\" class=\"nounderline abstract_t\">Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2015; 163:I.</a></li><li><a href=\"https://www.uptodate.com/contents/preventive-care-in-adults-recommendations/abstract/2\" class=\"nounderline abstract_t\">Siu AL, U.S. Preventive Services Task Force. Screening for high blood pressure in adults: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med 2015; 163:778.</a></li><li><a href=\"https://www.uptodate.com/contents/preventive-care-in-adults-recommendations/abstract/3\" class=\"nounderline abstract_t\">Centers for Disease Control and Prevention (CDC). Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine in adults aged 65 years and older - Advisory Committee on Immunization Practices (ACIP), 2012. MMWR Morb Mortal Wkly Rep 2012; 61:468.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 7574 Version 70.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H39\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">PRIORITIZING PREVENTIVE SERVICES</a></li><li><a href=\"#H706892113\" id=\"outline-link-H706892113\">OLDER ADULTS</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">CARDIOVASCULAR DISEASE</a><ul><li><a href=\"#H758233141\" id=\"outline-link-H758233141\">Cardiovascular risk assessment</a></li><li><a href=\"#H540017025\" id=\"outline-link-H540017025\">Hypertension</a></li><li><a href=\"#H540017031\" id=\"outline-link-H540017031\">Hyperlipidemia</a></li><li><a href=\"#H443482109\" id=\"outline-link-H443482109\">Obesity</a></li><li><a href=\"#H18816530\" id=\"outline-link-H18816530\">Physical activity</a></li><li><a href=\"#H706893344\" id=\"outline-link-H706893344\">Diabetes mellitus</a></li><li><a href=\"#H706894080\" id=\"outline-link-H706894080\">Aspirin for primary prevention</a></li><li><a href=\"#H443482115\" id=\"outline-link-H443482115\">Routine electrocardiogram</a></li><li><a href=\"#H200699475\" id=\"outline-link-H200699475\">Nontraditional measures</a></li></ul></li><li><a href=\"#H9\" id=\"outline-link-H9\">CANCER</a><ul><li><a href=\"#H540019999\" id=\"outline-link-H540019999\">Prevention</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">Breast cancer</a></li><li><a href=\"#H11\" id=\"outline-link-H11\">Cervical cancer</a></li><li><a href=\"#H179776045\" id=\"outline-link-H179776045\">Ovarian cancer</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">Colorectal cancer</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">Lung cancer</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">Prostate cancer</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">Melanoma</a></li></ul></li><li><a href=\"#H18\" id=\"outline-link-H18\">IMMUNIZATION</a></li><li><a href=\"#H28\" id=\"outline-link-H28\">SEXUALLY TRANSMITTED AND BLOODBORNE INFECTIONS</a></li><li><a href=\"#H18815683\" id=\"outline-link-H18815683\">PSYCHOSOCIAL HEALTH CONCERNS</a><ul><li><a href=\"#H706893450\" id=\"outline-link-H706893450\">Depression</a></li><li><a href=\"#H32\" id=\"outline-link-H32\">Substance related problems</a></li><li><a href=\"#H706893543\" id=\"outline-link-H706893543\">Intimate partner violence</a></li></ul></li><li><a href=\"#H18815956\" id=\"outline-link-H18815956\">OSTEOPOROSIS</a></li><li><a href=\"#H18816040\" id=\"outline-link-H18816040\">VASCULAR DISEASE</a></li><li><a href=\"#PATIENT_INFORMATION\" id=\"outline-link-H30779570\">INFORMATION FOR PATIENTS</a></li><li><a href=\"#H39\" id=\"outline-link-H39\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"PC/7574|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=ID/82634\" class=\"graphic graphic_figure\">- Vaccine schedule for healthy adults</a></li><li><a href=\"image.htm?imageKey=ID/62130\" class=\"graphic graphic_figure\">- Vaccine schedule based on medical conditions</a></li></ul></li><li><div id=\"PC/7574|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=PC/65157\" class=\"graphic graphic_table\">- Criteria preventive care</a></li><li><a href=\"image.htm?imageKey=PC/72728\" class=\"graphic graphic_table\">- Screening and prevention, adults younger than 65 years</a></li><li><a href=\"image.htm?imageKey=PC/75220\" class=\"graphic graphic_table\">- Recommended screening for adults over 65 years</a></li><li><a href=\"image.htm?imageKey=PEDS/76041\" class=\"graphic graphic_table\">- NHLBI panel screening guidelines for pediatric dyslipidemia</a></li><li><a href=\"image.htm?imageKey=PC/64508\" class=\"graphic graphic_table\">- Risk factors breast cancer</a></li><li><a href=\"image.htm?imageKey=ONC/65717\" class=\"graphic graphic_table\">- Risk assess crit breast ovar CA</a></li><li><a href=\"image.htm?imageKey=PC/94497\" class=\"graphic graphic_table\">- Benefit-harm of annual screen, by age</a></li><li><a href=\"image.htm?imageKey=PC/108744\" class=\"graphic graphic_table\">- USPSTF CRC screening summary</a></li><li><a href=\"image.htm?imageKey=ID/86782\" class=\"graphic graphic_table\">- Pneumococcal vaccination recommendations for adults</a></li><li><a href=\"image.htm?imageKey=ID/71265\" class=\"graphic graphic_table\">- Meningococcal vaccination indications in the US</a></li><li><a href=\"image.htm?imageKey=PEDS/116656\" class=\"graphic graphic_table\">- Target groups HBV vaccination</a></li><li><a href=\"image.htm?imageKey=GAST/55052\" class=\"graphic graphic_table\">- Screening for HBV</a></li><li><a href=\"image.htm?imageKey=ID/98092\" class=\"graphic graphic_table\">- Indications to test for HCV infection</a></li><li><a href=\"image.htm?imageKey=PC/89663\" class=\"graphic graphic_table\">- PHQ-2 questionnaire</a></li><li><a href=\"image.htm?imageKey=PC/59307\" class=\"graphic graphic_table\">- PHQ-9 questionnaire</a></li><li><a href=\"image.htm?imageKey=PC/53246\" class=\"graphic graphic_table\">- AUDIT-C</a></li><li><a href=\"image.htm?imageKey=PC/53373\" class=\"graphic graphic_table\">- Patients who should be asked about intimate partner violence</a></li><li><a href=\"image.htm?imageKey=ENDO/76445\" class=\"graphic graphic_table\">- Risk factors for osteoporosis</a></li></ul></li></ul></div></div><div><h2>CALCULATORS</h2><div id=\"outlineCalculators\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=calculator-cardiovascular-risk-assessment-10-year-general-cardiovascular-disease-men-framingham-2008-paper\" title=\"calculator 1\" class=\"calc calc_professional\">Calculator: Cardiovascular risk assessment (10-year, general cardiovascular disease, men: Framingham, 2008 paper)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=calculator-cardiovascular-risk-assessment-10-year-general-cardiovascular-disease-women-framingham-2008-paper\" title=\"calculator 2\" class=\"calc calc_professional\">Calculator: Cardiovascular risk assessment (10-year, general cardiovascular disease, women: Framingham, 2008 paper)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=calculator-body-mass-index-bmi-quetelets-index-in-adults\" title=\"calculator 3\" class=\"calc calc_professional\">Calculator: Body mass index (BMI; Quetelet's index) in adults</a></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=aspirin-in-the-primary-prevention-of-cardiovascular-disease-and-cancer\" class=\"medical medical_review\">Aspirin in the primary prevention of cardiovascular disease and cancer</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=blood-pressure-measurement-in-the-diagnosis-and-management-of-hypertension-in-adults\" class=\"medical medical_review\">Blood pressure measurement in the diagnosis and management of hypertension in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=c-reactive-protein-in-cardiovascular-disease\" class=\"medical medical_review\">C-reactive protein in cardiovascular disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cancer-prevention\" class=\"medical medical_review\">Cancer prevention</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cardiovascular-disease-risk-assessment-for-primary-prevention-our-approach\" class=\"medical medical_review\">Cardiovascular disease risk assessment for primary prevention: Our approach</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cardiovascular-disease-risk-assessment-for-primary-prevention-risk-calculators\" class=\"medical medical_review\">Cardiovascular disease risk assessment for primary prevention: Risk calculators</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cardiovascular-risk-of-smoking-and-benefits-of-smoking-cessation\" class=\"medical medical_review\">Cardiovascular risk of smoking and benefits of smoking cessation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cardiovascular-risks-of-hypertension\" class=\"medical medical_review\">Cardiovascular risks of hypertension</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=carotid-intima-media-thickness\" class=\"medical medical_review\">Carotid intima-media thickness</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=cigarette-smoking-and-other-possible-risk-factors-for-lung-cancer\" class=\"medical medical_review\">Cigarette smoking and other possible risk factors for lung cancer</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-assessment-of-substance-use-disorders\" class=\"medical medical_review\">Clinical assessment of substance use disorders</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-manifestations-and-diagnosis-of-neisseria-gonorrhoeae-infection-in-adults-and-adolescents\" class=\"medical medical_review\">Clinical manifestations and diagnosis of Neisseria gonorrhoeae infection in adults and adolescents</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=diagnostic-and-prognostic-implications-of-coronary-artery-calcification\" class=\"medical medical_review\">Diagnostic and prognostic implications of coronary artery calcification</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=dyslipidemia-in-children-definition-screening-and-diagnosis\" class=\"medical medical_review\">Dyslipidemia in children: Definition, screening, and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=evidence-based-approach-to-prevention\" class=\"medical medical_review\">Evidence-based approach to prevention</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=exercise-and-fitness-in-the-prevention-of-cardiovascular-disease\" class=\"medical medical_review\">Exercise and fitness in the prevention of cardiovascular disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=factors-that-modify-breast-cancer-risk-in-women\" class=\"medical medical_review\">Factors that modify breast cancer risk in women</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=familial-adenomatous-polyposis-screening-and-management-of-patients-and-families\" class=\"medical medical_review\">Familial adenomatous polyposis: Screening and management of patients and families</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=geriatric-health-maintenance\" class=\"medical medical_review\">Geriatric health maintenance</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=healthy-diet-in-adults\" class=\"medical medical_review\">Healthy diet in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hepatitis-b-virus-vaccination\" class=\"medical medical_review\">Hepatitis B virus vaccination</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=hepatitis-b-virus-screening-and-diagnosis\" class=\"medical medical_review\">Hepatitis B virus: Screening and diagnosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=human-papillomavirus-vaccination\" class=\"medical medical_review\">Human papillomavirus vaccination</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=immunizations-for-health-care-providers\" class=\"medical medical_review\">Immunizations for health care providers</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=immunizations-in-adults-with-cancer\" class=\"medical medical_review\">Immunizations in adults with cancer</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=intimate-partner-violence-diagnosis-and-screening\" class=\"medical medical_review\">Intimate partner violence: Diagnosis and screening</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=juvenile-polyposis-syndrome\" class=\"medical medical_review\">Juvenile polyposis syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=lipoprotein-a-and-cardiovascular-disease\" class=\"medical medical_review\">Lipoprotein(a) and cardiovascular disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=lynch-syndrome-hereditary-nonpolyposis-colorectal-cancer-screening-and-management\" class=\"medical medical_review\">Lynch syndrome (hereditary nonpolyposis colorectal cancer): Screening and management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-elevated-low-density-lipoprotein-cholesterol-ldl-c-in-primary-prevention-of-cardiovascular-disease\" class=\"medical medical_review\">Management of elevated low density lipoprotein-cholesterol (LDL-C) in primary prevention of cardiovascular disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=management-of-patients-at-high-risk-for-breast-and-ovarian-cancer\" class=\"medical medical_review\">Management of patients at high risk for breast and ovarian cancer</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=meningococcal-vaccines\" class=\"medical medical_review\">Meningococcal vaccines</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=nsaids-including-aspirin-role-in-prevention-of-colorectal-cancer\" class=\"medical medical_review\">NSAIDs (including aspirin): Role in prevention of colorectal cancer</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=obesity-in-adults-overview-of-management\" class=\"medical medical_review\">Obesity in adults: Overview of management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=obesity-in-adults-prevalence-screening-and-evaluation\" class=\"medical medical_review\">Obesity in adults: Prevalence, screening, and evaluation</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=obesity-weight-reduction-and-cardiovascular-disease\" class=\"medical medical_review\">Obesity, weight reduction, and cardiovascular disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=osteoporotic-fracture-risk-assessment\" class=\"medical medical_review\">Osteoporotic fracture risk assessment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-cancer-survivorship-care-for-primary-care-and-oncology-providers\" class=\"medical medical_review\">Overview of cancer survivorship care for primary care and oncology providers</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-dual-energy-x-ray-absorptiometry\" class=\"medical medical_review\">Overview of dual-energy x-ray absorptiometry</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-hereditary-breast-and-ovarian-cancer-syndromes\" class=\"medical medical_review\">Overview of hereditary breast and ovarian cancer syndromes</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-homocysteine\" class=\"medical medical_review\">Overview of homocysteine</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-hypertension-in-adults\" class=\"medical medical_review\">Overview of hypertension in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-medical-care-in-adults-with-diabetes-mellitus\" class=\"medical medical_review\">Overview of medical care in adults with diabetes mellitus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-primary-prevention-of-coronary-heart-disease-and-stroke\" class=\"medical medical_review\">Overview of primary prevention of coronary heart disease and stroke</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=overview-of-smoking-cessation-management-in-adults\" class=\"medical medical_review\">Overview of smoking cessation management in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=breast-cancer-screening-the-basics\" class=\"medical medical_basics\">Patient education: Breast cancer screening (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=lung-cancer-screening-the-basics\" class=\"medical medical_basics\">Patient education: Lung cancer screening (The Basics)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=pneumococcal-vaccination-in-adults\" class=\"medical medical_review\">Pneumococcal vaccination in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=prenatal-care-initial-assessment\" class=\"medical medical_review\">Prenatal care: Initial assessment</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=prenatal-care-second-and-third-trimesters\" class=\"medical medical_review\">Prenatal care: Second and third trimesters</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=prevalence-of-and-risk-factors-for-coronary-heart-disease-in-diabetes-mellitus\" class=\"medical medical_review\">Prevalence of and risk factors for coronary heart disease in diabetes mellitus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=prevention-of-sepsis-in-the-asplenic-patient\" class=\"medical medical_review\">Prevention of sepsis in the asplenic patient</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=prevention-of-sexually-transmitted-infections\" class=\"medical medical_review\">Prevention of sexually transmitted infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=preventive-care-in-adults-strategies-for-prioritization-and-delivery\" class=\"medical medical_review\">Preventive care in adults: Strategies for prioritization and delivery</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=primary-care-of-gay-men-and-men-who-have-sex-with-men\" class=\"medical medical_review\">Primary care of gay men and men who have sex with men</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=primary-care-of-the-hiv-infected-adult\" class=\"medical medical_review\">Primary care of the HIV-infected adult</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=screening-and-diagnostic-testing-for-hiv-infection\" class=\"medical medical_review\">Screening and diagnostic testing for HIV infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=screening-and-early-detection-of-melanoma-in-adults-and-adolescents\" class=\"medical medical_review\">Screening and early detection of melanoma in adults and adolescents</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=screening-for-abdominal-aortic-aneurysm\" class=\"medical medical_review\">Screening for abdominal aortic aneurysm</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=screening-for-asymptomatic-carotid-artery-stenosis\" class=\"medical medical_review\">Screening for asymptomatic carotid artery stenosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=screening-for-breast-cancer-evidence-for-effectiveness-and-harms\" class=\"medical medical_review\">Screening for breast cancer: Evidence for effectiveness and harms</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=screening-for-breast-cancer-strategies-and-recommendations\" class=\"medical medical_review\">Screening for breast cancer: Strategies and recommendations</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=screening-for-cervical-cancer\" class=\"medical medical_review\">Screening for cervical cancer</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=screening-for-cervical-cancer-in-hiv-infected-women-and-adolescents\" class=\"medical medical_review\">Screening for cervical cancer in HIV-infected women and adolescents</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=screening-for-chronic-hepatitis-c-virus-infection\" class=\"medical medical_review\">Screening for chronic hepatitis C virus infection</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=screening-for-colorectal-cancer-in-patients-with-a-family-history-of-colorectal-cancer\" class=\"medical medical_review\">Screening for colorectal cancer in patients with a family history of colorectal cancer</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=screening-for-colorectal-cancer-strategies-in-patients-at-average-risk\" class=\"medical medical_review\">Screening for colorectal cancer: Strategies in patients at average risk</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=screening-for-coronary-heart-disease\" class=\"medical medical_review\">Screening for coronary heart disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=screening-for-depression-in-adults\" class=\"medical medical_review\">Screening for depression in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=screening-for-lipid-disorders-in-adults\" class=\"medical medical_review\">Screening for lipid disorders in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=screening-for-lower-extremity-peripheral-artery-disease\" class=\"medical medical_review\">Screening for lower extremity peripheral artery disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=screening-for-lung-cancer\" class=\"medical medical_review\">Screening for lung cancer</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=screening-for-osteoporosis\" class=\"medical medical_review\">Screening for osteoporosis</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=screening-for-ovarian-cancer\" class=\"medical medical_review\">Screening for ovarian cancer</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=screening-for-prostate-cancer\" class=\"medical medical_review\">Screening for prostate cancer</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=screening-for-sexually-transmitted-infections\" class=\"medical medical_review\">Screening for sexually transmitted infections</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=screening-for-type-2-diabetes-mellitus\" class=\"medical medical_review\">Screening for type 2 diabetes mellitus</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=screening-for-unhealthy-use-of-alcohol-and-other-drugs-in-primary-care\" class=\"medical medical_review\">Screening for unhealthy use of alcohol and other drugs in primary care</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=seasonal-influenza-vaccination-in-adults\" class=\"medical medical_review\">Seasonal influenza vaccination in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=standard-immunizations-for-nonpregnant-adults\" class=\"medical medical_review\">Standard immunizations for nonpregnant adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=surveillance-and-management-of-dysplasia-in-patients-with-inflammatory-bowel-disease\" class=\"medical medical_review\">Surveillance and management of dysplasia in patients with inflammatory bowel disease</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=syphilis-screening-and-diagnostic-testing\" class=\"medical medical_review\">Syphilis: Screening and diagnostic testing</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=tetanus-diphtheria-toxoid-vaccination-in-adults\" class=\"medical medical_review\">Tetanus-diphtheria toxoid vaccination in adults</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=the-benefits-and-risks-of-exercise\" class=\"medical medical_review\">The benefits and risks of exercise</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=vaccination-for-the-prevention-of-chickenpox-primary-varicella-infection\" class=\"medical medical_review\">Vaccination for the prevention of chickenpox (primary varicella infection)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=what-is-goal-blood-pressure-in-the-treatment-of-hypertension\" class=\"medical medical_review\">What is goal blood pressure in the treatment of hypertension?</a></li></ul></div></div>","javascript":null}